| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 70% | 14/20 |
| Female | 30% | 6/20 |
| Indifferent | 0% | 0/20 |
| Unknown | 0% | 0/20 |
| General | ||
| Birth Length | 0% | 0/20 |
| Birth Weight | 0% | 0/20 |
| Birth Head circumference | 0% | 0/20 |
| 25% | 5/20 | |
| 20% | 4/20 | |
| 15% | 3/20 | |
| 85% | 17/20 | |
| 100% | 20/20 | |
| 75% | 15/20 | |
| 81.3% | 13/16 | |
| Neurology | ||
| 65% | 13/20 | |
| 60% | 12/20 | |
| 25% | 5/20 | |
| Facial abnormalities | ||
| 20% | 4/20 | |
| 70% | 14/20 | |
| 55% | 11/20 | |
| 60% | 12/20 | |
| Visual and hearing impairments | ||
| Abnormal hearing | 0% | 0/20 |
| 20% | 4/20 | |
| Heart | ||
| 15% | 3/20 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/20 |
| Gastrointestinal | ||
| 5% | 1/20 | |
| Urogenital | ||
| 25% | 5/20 | |
| Skeleton | ||
| 50% | 10/20 | |
| Skin / Hair / Nails | ||
| 60% | 12/20 | |
| Endocrine / Immunological / Metabolic | ||
| 5% | 1/20 | |
| Metabolic | 0% | 0/20 |
| 15% | 3/20 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/20 |
| Inheritance | ||
| 80% | 16/20 | |
JARID2